UnitedHealth Group Inc. (UNH) Receives “Buy” Rating from Jefferies Group
UnitedHealth Group Inc. (NYSE:UNH)‘s stock had its “buy” rating reiterated by analysts at Jefferies Group in a research note issued on Tuesday. They presently have a $163.00 target price on the healthcare conglomerate’s stock. Jefferies Group’s price target points to a potential upside of 17.70% from the company’s current price.
UNH has been the subject of several other reports. Credit Suisse Group AG restated a “buy” rating and set a $155.00 target price (up from $148.00) on shares of UnitedHealth Group in a report on Wednesday, July 20th. Zacks Investment Research cut UnitedHealth Group from a “hold” rating to a “sell” rating in a report on Monday, July 18th. Leerink Swann restated a “buy” rating on shares of UnitedHealth Group in a report on Monday, June 27th. FBR & Co restated an “outperform” rating and set a $155.00 target price (up from $145.00) on shares of UnitedHealth Group in a report on Wednesday, July 20th. Finally, Royal Bank Of Canada increased their target price on UnitedHealth Group from $157.00 to $165.00 and gave the company an “outperform” rating in a report on Wednesday, July 20th. One equities research analyst has rated the stock with a hold rating, twenty-four have given a buy rating and one has given a strong buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus target price of $155.35.
Shares of UnitedHealth Group (NYSE:UNH) opened at 138.49 on Tuesday. The firm has a 50-day moving average price of $138.30 and a 200-day moving average price of $136.18. The firm has a market cap of $131.90 billion, a PE ratio of 21.67 and a beta of 0.57. UnitedHealth Group has a 52 week low of $107.51 and a 52 week high of $144.48.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 19th. The healthcare conglomerate reported $1.96 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.89 by $0.07. UnitedHealth Group had a return on equity of 19.08% and a net margin of 3.51%. The firm earned $46.50 billion during the quarter, compared to analysts’ expectations of $45.05 billion. On average, equities research analysts predict that UnitedHealth Group will post $7.90 earnings per share for the current year.
The company also recently declared a quarterly dividend, which was paid on Tuesday, September 20th. Stockholders of record on Friday, September 9th were paid a $0.625 dividend. The ex-dividend date was Tuesday, September 6th. This represents a $2.50 dividend on an annualized basis and a dividend yield of 1.81%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 39.12%.
In other news, Director Richard T. Burke sold 40,000 shares of the firm’s stock in a transaction on Wednesday, September 7th. The stock was sold at an average price of $135.31, for a total value of $5,412,400.00. Following the transaction, the director now directly owns 2,003,550 shares in the company, valued at approximately $271,100,350.50. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. 1.65% of the stock is owned by insiders.
Several institutional investors have recently added to or reduced their stakes in UNH. Factory Mutual Insurance Co. increased its position in UnitedHealth Group by 17.4% in the first quarter. Factory Mutual Insurance Co. now owns 289,600 shares of the healthcare conglomerate’s stock worth $37,329,000 after buying an additional 43,000 shares during the period. Apex Capital Management boosted its position in shares of UnitedHealth Group by 0.3% in the first quarter. Apex Capital Management now owns 7,281 shares of the healthcare conglomerate’s stock worth $939,000 after buying an additional 24 shares in the last quarter. Telemus Capital LLC boosted its position in shares of UnitedHealth Group by 31.6% in the first quarter. Telemus Capital LLC now owns 40,301 shares of the healthcare conglomerate’s stock worth $5,195,000 after buying an additional 9,666 shares in the last quarter. Commonwealth Equity Services Inc boosted its position in shares of UnitedHealth Group by 0.3% in the first quarter. Commonwealth Equity Services Inc now owns 112,173 shares of the healthcare conglomerate’s stock worth $14,459,000 after buying an additional 373 shares in the last quarter. Finally, Aperio Group LLC boosted its position in shares of UnitedHealth Group by 6.8% in the first quarter. Aperio Group LLC now owns 643,082 shares of the healthcare conglomerate’s stock worth $82,893,000 after buying an additional 40,859 shares in the last quarter. Hedge funds and other institutional investors own 85.78% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Stock Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related stocks with our FREE daily email newsletter.